HCPLive Network

Hyponatremia Discussion and Explanation

 
Below you will find parts 1 and 2 of “Hyponatremia Explained Clearly,” which are part of Dr. Roger Seheult’s terrific MedCram video series (which offers “Medical Topics Explained Clearly by World-Class Instructors”).
 
Hyponatremia Explained Clearly – Part 1
 

 
Hyponatremia Explained Clearly – Part 2 of 4
 

 
 
Visit the MedCram YouTube page to access parts 3 and 4, as well as dozens of other high-quality informative videos on a wide range of medical topics.
 

Further Reading
Researchers at Hong Kong University and the Wellcome Trust Sanger Institute have identified a link between the influenza A viruses’ genetic diversity and severity of the infection.
Carol Burke, MD, FACG, FASGE, talks about her phase-3 placebo-controlled trial of Celecoxib in pediatric subjects with familial adenomatous polyposis (FAP) at the 2014 ACG Annual Meeting in Philadelphia, PA.
Carol Burke, MD, FACG, FASGE, discusses pediatric familial adenomatous polyposis (FAP) and colorectal cancer at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.
The immune system is the new focus of much work on traumatic brain injury (TBI). In a challenge to the paradigm that the blood brain barrier prevents harmful leukocytes from entering the brain, a Texas team tried to neutralize the impact of these cells. Peripheral lymphocytes are activated after TBI. They may then act as potential antigen presenting cells and get into the brain, causing cells there to degenerate.
Depressive symptoms are associated with poorer long-term outcome in patients undergoing surgery for lumbar spinal stenosis (LSS), according to research published in the Oct. 1 issue of The Spine Journal.
Maternal eating disorders are associated with adverse pregnancy, obstetric, and perinatal health outcomes, according to a study published in the October issue of the American Journal of Obstetrics & Gynecology.
High-risk asymptomatic patients with diabetes mellitus and normal myocardial perfusion single-photon emission computed tomography have a low rate of first manifestations of coronary artery disease; however, patients with DM and abnormal MPS have a seven-fold higher rate of progression to overt or silent CAD despite therapy. These findings were published in the Oct. 1 issue of JACC: Cardiovascular Imaging.
More Reading